Tue, September 12, 2023
Mon, September 11, 2023
Fri, September 8, 2023
Thu, September 7, 2023
Wed, September 6, 2023
Tue, September 5, 2023

Li Watsek Reiterated (ASND) at Buy and Held Target at $152 on, Sep 7th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-152-on-sep-7th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Li Watsek of Cantor Fitzgerald, Reiterated "Ascendis Pharma A/S" (ASND) at Buy and Held Target at $152 on, Sep 7th, 2023.

Li has made no other calls on ASND in the last 4 months.



There are 4 other peers that have a rating on ASND. Out of the 4 peers that are also analyzing ASND, 2 agree with Li's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $113 on, Wednesday, September 6th, 2023
  • Tiago Fauth of "Credit Suisse" Initiated at Hold and Held Target at $89 on, Wednesday, June 14th, 2023


These are the ratings of the 2 analyists that currently disagree with Li


  • Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $192 on, Wednesday, September 6th, 2023
  • Derek Archila of "Wells Fargo" Maintained at Buy with Decreased Target to $134 on, Wednesday, September 6th, 2023

Publication Contributing Sources